Carboplatin+Nab-paclitaxel, Plus Trastuzumab (HER2+) or Bevacizumab (HER2-) in the Neoadjuvant Setting
Clinical trial NCT00618657 · COMPLETED
Trial details
- NCT number
- NCT00618657
- Sponsor
- University of California, Irvine
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-02-01
- Primary completion
- 2021-07-01
- Enrollment
- 127
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.